Jehane Ibrahim Eid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jehane Ibrahim Eid has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
Akmal A. El-Ghor
Zoology Department, Faculty of Science, Cairo University, Giza 12613, Egypt
4 shared publications- Biswadeep Das
School of Biotechnology, Kalinga Institute of Industrial Technology, Deemed to be University, Bhubaneswar, India
4 shared publications Magda M. Noshy
Zoology Department, Faculty of Science, Cairo University, Giza 12613, Egypt
3 shared publicationsSwabhiman Mohanty
School of Biotechnology, KIIT University, Bhubaneswar 751024, India
3 shared publicationsDoaa F. Teleb
Sheep & Goat Research Department, Animal Production Research Institute, 12611 Dokki, Giza, Egypt
2 shared publicationsMajdah Mohammad Al-Tuwaijri
Department of Biology, Faculty of Applied Sciences. Umm Al-Qura University, Makkah, Saudi Arabia
2 shared publications
Latest Publications
- 28 July 2026
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 198 (12) , 10348-10373
Biosynthesis of Silver and Gold Nanoparticles using Inonotus obliquus: A strategy for Antimicrobial, Antioxidant and Cytotoxic Applications
- 28 July 2026
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 198 (12) , 10348-10373
Biosynthesis of Silver and Gold Nanoparticles using Inonotus obliquus: A strategy for Antimicrobial, Antioxidant and Cytotoxic Applications
- Open Access
- 5 June 2026
- Published by Springer Nature in The Journal of Basic and Applied Zoology
- Vol. 87 (1)
Adipose-derived mesenchymal stem cells attenuate doxorubicin-induced cardiomyopathy in rats: association with miR-146a/NF-κB/TLR-4 transcriptional modulation
Background: Doxorubicin (DOX) is an effective chemotherapeutic drug, but its clinical use is limited by dose-dependent cardiotoxicity and cardiomyopathy. Adipose-derived mesenchymal stem cells (ADMSCs) may offer cardioprotective effects through regenerative, antioxidant, and immunomodulatory mechanisms. This study investigated the therapeutic potential of ADMSCs in DOX-induced cardiomyopathy in rats, with focus on miR-146a expression and transcriptional modulation of the NF-κB/TLR-4 inflammatory signaling axis. NF-κB was selected because it plays a central role in regulating inflammatory signaling and is well established as a key link between oxidative stress and myocardial injury in doxorubicin-induced cardiotoxicity, compared with other downstream apoptotic pathways. Methodology: Forty male rats were assigned to control and DOX-treated groups. Cardiomyopathy was induced by intraperitoneal DOX injection at 2.5 mg/kg every other day for 14 days, for a total of seven injections and a cumulative dose of 17.5 mg/kg. During the therapeutic phase, ADMSCs were administered intravenously. Serum creatine kinase activity, cardiac oxidative stress markers, miR-146a, NF-κB, and TLR-4 expression were assessed. Alkaline and neutral comet assays, histopathological examination, and ADMSC homing evaluation were also performed. Results: DOX administration increased serum creatine kinase activity and malondialdehyde levels, reduced catalase activity, and induced cardiac DNA damage and histopathological alterations. Molecular analysis showed a slight, non-significant downward trend in miR-146a expression during induction, together with significant upregulation of NF-κB and TLR-4 expression. ADMSC treatment ameliorated several DOX-associated biochemical, molecular, genotoxic, and histopathological alterations. However, some physiological parameters showed only partial or non-significant improvement. Conclusion: These findings suggest that ADMSCs may attenuate DOX-induced cardiomyopathy, at least partly, through reduced oxidative stress and DNA damage, improved myocardial histology, and transcriptional modulation of the miR-146a/NF-κB/TLR-4 axis.
- 5 June 2026
- Published by Springer Nature in The Journal of Basic and Applied Zoology
- Vol. 87 (1)
Open AccessAdipose-derived mesenchymal stem cells attenuate doxorubicin-induced cardiomyopathy in rats: association with miR-146a/NF-κB/TLR-4 transcriptional modulation
Background: Doxorubicin (DOX) is an effective chemotherapeutic drug, but its clinical use is limited by dose-dependent cardiotoxicity and cardiomyopathy. Adipose-derived mesenchymal stem cells (ADMSCs) may offer cardioprotective effects through regenerative, antioxidant, and immunomodulatory mechanisms. This study investigated the therapeutic potential of ADMSCs in DOX-induced cardiomyopathy in rats, with focus on miR-146a expression and transcriptional modulation of the NF-κB/TLR-4 inflammatory signaling axis. NF-κB was selected because it plays a central role in regulating inflammatory signaling and is well established as a key link between oxidative stress and myocardial injury in doxorubicin-induced cardiotoxicity, compared with other downstream apoptotic pathways. Methodology: Forty male rats were assigned to control and DOX-treated groups. Cardiomyopathy was induced by intraperitoneal DOX injection at 2.5 mg/kg every other day for 14 days, for a total of seven injections and a cumulative dose of 17.5 mg/kg. During the therapeutic phase, ADMSCs were administered intravenously. Serum creatine kinase activity, cardiac oxidative stress markers, miR-146a, NF-κB, and TLR-4 expression were assessed. Alkaline and neutral comet assays, histopathological examination, and ADMSC homing evaluation were also performed. Results: DOX administration increased serum creatine kinase activity and malondialdehyde levels, reduced catalase activity, and induced cardiac DNA damage and histopathological alterations. Molecular analysis showed a slight, non-significant downward trend in miR-146a expression during induction, together with significant upregulation of NF-κB and TLR-4 expression. ADMSC treatment ameliorated several DOX-associated biochemical, molecular, genotoxic, and histopathological alterations. However, some physiological parameters showed only partial or non-significant improvement. Conclusion: These findings suggest that ADMSCs may attenuate DOX-induced cardiomyopathy, at least partly, through reduced oxidative stress and DNA damage, improved myocardial histology, and transcriptional modulation of the miR-146a/NF-κB/TLR-4 axis.
- 11 April 2025
- Published by Elsevier in Tissue and Cell
- Vol. 95, 102916
Protective effects of Moringa oleifera leaf extract against cyclophosphamide-induced ovarian dysfunction and follicular loss in rats
- 11 April 2025
- Published by Elsevier in Tissue and Cell
- Vol. 95, 102916
Protective effects of Moringa oleifera leaf extract against cyclophosphamide-induced ovarian dysfunction and follicular loss in rats
- Open Access
- 21 September 2024
- Published by Springer Nature in Apoptosis
- Vol. 30 (1-2) , 35-54
β-glucan nanoparticles alleviate acute asthma by suppressing ferroptosis and DNA damage in mice
Asthma is a severe respiratory disease marked by airway inflammation, remodeling, and oxidative stress. β-Glucan (BG), a polysaccharide constituent of fungal cellular structures, exhibits potent immunomodulatory activities. The investigational focus was on the anti-asthmatic and anti-ferroptotic properties of beta-glucan nanoparticles (BG-NPs) in a murine model of allergic asthma induced by ovalbumin (OVA). BG was extracted from Chaga mushrooms (Inonotus obliquus), and its BG-NPs were characterized utilizing techniques including FT-IR, UV visible spectroscopy, zeta potential analysis, DLS, XRD, and TEM. The Balb/C mice were allocated into five groups: control, untreated asthmatic, dexamethasone (Dexa)-treated (1 mg/kg), BG-treated (100 mg/kg), BG-NPs-treated (45 mg/kg), and BG-treated (100 mg/kg). Treatment with BG-NPs markedly diminished the entry of inflammatory cells into the respiratory passage, serum IgE concentrations, DNA damage, and markers of oxidative stress through the reduction of malonaldehyde (MDA) levels and enhancing the levels of reduced glutathione (GSH), glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase (CAT). Furthermore, BG-NPs reduced iron deposition and promoted the transcriptional activity of the GPx4 gene in pulmonary cells, attenuating ferroptosis. The results demonstrated that BG-NPs reduced asthma by inhibiting oxidative stress, inflammation, DNA damage, and ferroptosis. Our results suggest that BG-NPs could be used as potential treatments for allergic asthma. Graphical abstract
- 21 September 2024
- Published by Springer Nature in Apoptosis
- Vol. 30 (1-2) , 35-54
Open Accessβ-glucan nanoparticles alleviate acute asthma by suppressing ferroptosis and DNA damage in mice
Asthma is a severe respiratory disease marked by airway inflammation, remodeling, and oxidative stress. β-Glucan (BG), a polysaccharide constituent of fungal cellular structures, exhibits potent immunomodulatory activities. The investigational focus was on the anti-asthmatic and anti-ferroptotic properties of beta-glucan nanoparticles (BG-NPs) in a murine model of allergic asthma induced by ovalbumin (OVA). BG was extracted from Chaga mushrooms (Inonotus obliquus), and its BG-NPs were characterized utilizing techniques including FT-IR, UV visible spectroscopy, zeta potential analysis, DLS, XRD, and TEM. The Balb/C mice were allocated into five groups: control, untreated asthmatic, dexamethasone (Dexa)-treated (1 mg/kg), BG-treated (100 mg/kg), BG-NPs-treated (45 mg/kg), and BG-treated (100 mg/kg). Treatment with BG-NPs markedly diminished the entry of inflammatory cells into the respiratory passage, serum IgE concentrations, DNA damage, and markers of oxidative stress through the reduction of malonaldehyde (MDA) levels and enhancing the levels of reduced glutathione (GSH), glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase (CAT). Furthermore, BG-NPs reduced iron deposition and promoted the transcriptional activity of the GPx4 gene in pulmonary cells, attenuating ferroptosis. The results demonstrated that BG-NPs reduced asthma by inhibiting oxidative stress, inflammation, DNA damage, and ferroptosis. Our results suggest that BG-NPs could be used as potential treatments for allergic asthma. Graphical abstract
- Open Access
- 5 June 2023
- Published by Qeios Ltd
Review of: "Natural Polyphenols of Pomegranate and Black Tea Juices can Combat COVID-19 through their SARS-CoV-2 3C-like Protease-inhibitory Activity."
Upon thorough examination of the article "Natural Polyphenols of Pomegranate and Black Tea Juices can Combat COVID-19 through their SARS-CoV-2 3C-like Protease-inhibitory Activity" by Saeed Reza Hormozi Jangi, I suggest several modifications to impro...
- 5 June 2023
- Published by Qeios Ltd
Open AccessReview of: "Natural Polyphenols of Pomegranate and Black Tea Juices can Combat COVID-19 through their SARS-CoV-2 3C-like Protease-inhibitory Activity."
Upon thorough examination of the article "Natural Polyphenols of Pomegranate and Black Tea Juices can Combat COVID-19 through their SARS-CoV-2 3C-like Protease-inhibitory Activity" by Saeed Reza Hormozi Jangi, I suggest several modifications to impro...
- Open Access
- 16 February 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-11
An insight into synthesis and antitumor activity of citrate and gallate stabilizing gold nanospheres
Both gallic and citrate are well-established antioxidants that show promise as new selective anti-cancer drugs. Gold nanoparticles (AuNPs) as well can be developed as flexible and nontoxic nano-carriers for anti-cancer drugs. This article evaluating the efficiency and biocompatibility of gallic acid and citrate capping gold nanoparticles to be used as anti-cancer drug. The biosafety and therapeutic efficiency of prepared nano-formulations were tested on Hela and normal BHK cell line. Gold nanospheres coated with citrate and gallate were synthesized via wet chemical reduction method. The prepared nano-formulations, citrate and gallate coated gold nanospheres (Cit-AuNPs and Ga-AuNPs), were characterized with respect to their morphology, FTIR spectra, and physical properties. In addition, to assess their cytotoxicity, cell cycle arrest and flow cytometry to measure biological response were performed. Cit-Au NPs and Ga-Au NPs were shown to significantly reduce the viability of Hela cancer cells. Both G0/G cell cycle arrest and comet assay results showed that genotoxic effect was induced in Hela cells by Cit-Au NPs and Ga-Au NPs. The results of this study showed that Cit-Au NPs and Ga-AuNPs inhibit the growth of metastatic cervical cancer cells, which could have therapeutic implications.
- 16 February 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-11
Open AccessAn insight into synthesis and antitumor activity of citrate and gallate stabilizing gold nanospheres
Both gallic and citrate are well-established antioxidants that show promise as new selective anti-cancer drugs. Gold nanoparticles (AuNPs) as well can be developed as flexible and nontoxic nano-carriers for anti-cancer drugs. This article evaluating the efficiency and biocompatibility of gallic acid and citrate capping gold nanoparticles to be used as anti-cancer drug. The biosafety and therapeutic efficiency of prepared nano-formulations were tested on Hela and normal BHK cell line. Gold nanospheres coated with citrate and gallate were synthesized via wet chemical reduction method. The prepared nano-formulations, citrate and gallate coated gold nanospheres (Cit-AuNPs and Ga-AuNPs), were characterized with respect to their morphology, FTIR spectra, and physical properties. In addition, to assess their cytotoxicity, cell cycle arrest and flow cytometry to measure biological response were performed. Cit-Au NPs and Ga-Au NPs were shown to significantly reduce the viability of Hela cancer cells. Both G0/G cell cycle arrest and comet assay results showed that genotoxic effect was induced in Hela cells by Cit-Au NPs and Ga-Au NPs. The results of this study showed that Cit-Au NPs and Ga-AuNPs inhibit the growth of metastatic cervical cancer cells, which could have therapeutic implications.
- Open Access
- 1 June 2022
- Published by Egyptian Knowledge Bank in Egyptian Journal of Animal Production
- Vol. 59 (5) , 35-40
ASSOCIATION OF NEW SNPs AT DGAT1 GENE WITH MILK QUALITY IN EGYPTIAN ZARAIBI GOAT BREED
SUMMARY This study aimed to detect putative genomic loci in candidate genes associated with milk composition in Egyptian Zaraibi goats. A total number of 50 samples were tested to detect polymorphism in exons 15 and 16 of the diacylglycerol acyltransferase 1 (DGAT1) gene. The PCR products of different electrophoresis patterns were sequenced and aligned with multiple sequence alignment tools (Clastal Omega and Jalview). Sequence analysis showed three new genotypes in the studied samples: the first was BB with C12T and G219A SNPs, the second DD contains C84T and G219A SNPs and the third was AG genotype with only G219A SNP. General Linear Model Analysis (GLM) showed that the DD genotype group with C84T and G219A SNPs had significantly the highest fat percent. Meanwhile, BB genotype group with C84T and G219A SNPs recorded significantly the highest total solids levels. On the other hand, the AG genotype group which has G219A SNP showed non-significant effect on milk components. Those new SNPs were submitted to GenBank and approved by accession number OM418856, OM418857 and OM418858 to be published. Moreover, translation of those sequences showed that the G219A SNP causes a substitution of Glycine to Serine in exon 16 at position 106. This SNP (G106S) was predicted to be tolerated by SIFT with a score of 0.48. Substitution of Glycine (which is a small amino acid located on the surface of the protein) to Serine (which is larger than glycine) could lead to losses of several interactions with adjacent molecules in the protein structure. In conclusion, the results demonstrated several genetic variations in DGAT1, which are associated with different milk composition, so it could be used as genetic markers for the selection of dairy goats in breeding programs to improve milk quality.
- 1 June 2022
- Published by Egyptian Knowledge Bank in Egyptian Journal of Animal Production
- Vol. 59 (5) , 35-40
Open AccessASSOCIATION OF NEW SNPs AT DGAT1 GENE WITH MILK QUALITY IN EGYPTIAN ZARAIBI GOAT BREED
SUMMARY This study aimed to detect putative genomic loci in candidate genes associated with milk composition in Egyptian Zaraibi goats. A total number of 50 samples were tested to detect polymorphism in exons 15 and 16 of the diacylglycerol acyltransferase 1 (DGAT1) gene. The PCR products of different electrophoresis patterns were sequenced and aligned with multiple sequence alignment tools (Clastal Omega and Jalview). Sequence analysis showed three new genotypes in the studied samples: the first was BB with C12T and G219A SNPs, the second DD contains C84T and G219A SNPs and the third was AG genotype with only G219A SNP. General Linear Model Analysis (GLM) showed that the DD genotype group with C84T and G219A SNPs had significantly the highest fat percent. Meanwhile, BB genotype group with C84T and G219A SNPs recorded significantly the highest total solids levels. On the other hand, the AG genotype group which has G219A SNP showed non-significant effect on milk components. Those new SNPs were submitted to GenBank and approved by accession number OM418856, OM418857 and OM418858 to be published. Moreover, translation of those sequences showed that the G219A SNP causes a substitution of Glycine to Serine in exon 16 at position 106. This SNP (G106S) was predicted to be tolerated by SIFT with a score of 0.48. Substitution of Glycine (which is a small amino acid located on the surface of the protein) to Serine (which is larger than glycine) could lead to losses of several interactions with adjacent molecules in the protein structure. In conclusion, the results demonstrated several genetic variations in DGAT1, which are associated with different milk composition, so it could be used as genetic markers for the selection of dairy goats in breeding programs to improve milk quality.
- Open Access
- 20 October 2021
- Published by Wiley in Food Science & Nutrition
- Vol. 9 (12) , 6513-6523
Targeting SARS‐CoV‐2 with Chaga mushroom: An in silico study toward developing a natural antiviral compound
The novel coronavirus (SARS‐CoV‐2) has caused large‐scale global outbreaks and mainly mediates host cell entry through the interaction of its spike (S) protein with the human angiotensin‐converting enzyme‐2 (ACE‐2) receptor. As there is no effective treatment for SARS‐CoV‐2 to date, it is imperative to explore the efficacy of new compounds that possess potential antiviral activity. In this study, we assessed the potential binding interaction of the beneficial components of Chaga mushroom, a natural anti‐inflammatory and immune booster with that of the SARS‐CoV‐2 receptor‐binding domain (RBD) using molecular docking, MD simulation, and phylogenetic analysis. Beta glycan, betulinic acid, and galactomannan constituents of Chaga mushroom exhibited strong binding interaction (−7.4 to −8.6 kcal/mol) forming multivalent hydrogen and non‐polar bonds with the viral S1‐carboxy‐terminal domain of the RBD. Specifically, the best interacting sites for beta glycan comprised ASN‐440, SER 373, TRP‐436, ASN‐343, and ARG 509 with average binding energy of −8.4 kcal/mol. The best interacting sites of galactomannan included ASN‐437, SER 373, TRP‐436, ASN‐343, and ALA 344 with a mean binding energy of −7.4 kcal/mol; and the best interacting sites of betulinic acid were ASN‐437, SER 373, TRP‐436, PHE 342, ARG 509, and ALA 344 that strongly interacted with the S‐protein (ΔG = −8.1 kcal/mol). The docking results were also compared with an S‐protein binding analog, NAG and depicted similar binding affinities compared with that of the ligands (−8.67 kcal/mol). In addition, phylogenetic analysis using global isolates depicted that the current SARS‐CoV‐2 isolates possessed a furin cleavage site (NSPRRA) in the RBD, which was absent in the previous isolates that indicated increased efficacy of the present virus for enhanced infection through increased interaction with ACE‐2. The results showed that Chaga could be an effective natural antiviral that can supplement the current anti‐SARS‐CoV‐2 drugs.
- 20 October 2021
- Published by Wiley in Food Science & Nutrition
- Vol. 9 (12) , 6513-6523
Open AccessTargeting SARS‐CoV‐2 with Chaga mushroom: An in silico study toward developing a natural antiviral compound
The novel coronavirus (SARS‐CoV‐2) has caused large‐scale global outbreaks and mainly mediates host cell entry through the interaction of its spike (S) protein with the human angiotensin‐converting enzyme‐2 (ACE‐2) receptor. As there is no effective treatment for SARS‐CoV‐2 to date, it is imperative to explore the efficacy of new compounds that possess potential antiviral activity. In this study, we assessed the potential binding interaction of the beneficial components of Chaga mushroom, a natural anti‐inflammatory and immune booster with that of the SARS‐CoV‐2 receptor‐binding domain (RBD) using molecular docking, MD simulation, and phylogenetic analysis. Beta glycan, betulinic acid, and galactomannan constituents of Chaga mushroom exhibited strong binding interaction (−7.4 to −8.6 kcal/mol) forming multivalent hydrogen and non‐polar bonds with the viral S1‐carboxy‐terminal domain of the RBD. Specifically, the best interacting sites for beta glycan comprised ASN‐440, SER 373, TRP‐436, ASN‐343, and ARG 509 with average binding energy of −8.4 kcal/mol. The best interacting sites of galactomannan included ASN‐437, SER 373, TRP‐436, ASN‐343, and ALA 344 with a mean binding energy of −7.4 kcal/mol; and the best interacting sites of betulinic acid were ASN‐437, SER 373, TRP‐436, PHE 342, ARG 509, and ALA 344 that strongly interacted with the S‐protein (ΔG = −8.1 kcal/mol). The docking results were also compared with an S‐protein binding analog, NAG and depicted similar binding affinities compared with that of the ligands (−8.67 kcal/mol). In addition, phylogenetic analysis using global isolates depicted that the current SARS‐CoV‐2 isolates possessed a furin cleavage site (NSPRRA) in the RBD, which was absent in the previous isolates that indicated increased efficacy of the present virus for enhanced infection through increased interaction with ACE‐2. The results showed that Chaga could be an effective natural antiviral that can supplement the current anti‐SARS‐CoV‐2 drugs.
- Open Access
- 7 April 2021
- Published by IntechOpen
SARS-CoV-2 and Coronavirus Ancestors under a Molecular Scope
The Pandemic of COVID-19 has been thoroughly followed and discussed on many levels due to the high level of attention that it has brought by its effect on the world. While this disease might seem like to arise out of the blue, we will shed light on COVID-19 disease which is caused by the virus SARS-CoV2 and belong to family of coronaviruses. We will discuss current knowledge about SARS-CoV2 emergence, diagnosis, its mode of action, and genomic information, For an antiviral treatment to be used, it should be preceded by a foundation of information about the virus genome and its family as discussed in this review.
- 7 April 2021
- Published by IntechOpen
Open AccessSARS-CoV-2 and Coronavirus Ancestors under a Molecular Scope
The Pandemic of COVID-19 has been thoroughly followed and discussed on many levels due to the high level of attention that it has brought by its effect on the world. While this disease might seem like to arise out of the blue, we will shed light on COVID-19 disease which is caused by the virus SARS-CoV2 and belong to family of coronaviruses. We will discuss current knowledge about SARS-CoV2 emergence, diagnosis, its mode of action, and genomic information, For an antiviral treatment to be used, it should be preceded by a foundation of information about the virus genome and its family as discussed in this review.